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Abstract
The polymodal transient receptor potential vanilloid 4 (TRPV4) channel, a member of the TRP channel family, is a calcium-
permeable cationic channel that is gated by various stimuli such as cell swelling, low pH and high temperature. Therefore,
TRPV4-mediated calcium entry may be involved in neuronal and glia pathophysiology associated with various disorders of
the central nervous system, such as ischemia. The TRPV4 channel has been recently found in adult rat cortical and
hippocampal astrocytes; however, its role in astrocyte pathophysiology is still not defined. In the present study, we
examined the impact of cerebral hypoxia/ischemia (H/I) on the functional expression of astrocytic TRPV4 channels in the
adult rat hippocampal CA1 region employing immunohistochemical analyses, the patch-clamp technique and
microfluorimetric intracellular calcium imaging on astrocytes in slices as well as on those isolated from sham-operated
or ischemic hippocampi. Hypoxia/ischemia was induced by a bilateral 15-minute occlusion of the common carotids
combined with hypoxic conditions. Our immunohistochemical analyses revealed that 7 days after H/I, the expression of
TRPV4 is markedly enhanced in hippocampal astrocytes of the CA1 region and that the increasing TRPV4 expression
coincides with the development of astrogliosis. Additionally, adult hippocampal astrocytes in slices or cultured hippocampal
astrocytes respond to the TRPV4 activator 4-alpha-phorbol-12,-13-didecanoate (4aPDD) by an increase in intracellular
calcium and the activation of a cationic current, both of which are abolished by the removal of extracellular calcium or
exposure to TRP antagonists, such as Ruthenium Red or RN1734. Following hypoxic/ischemic injury, the responses of
astrocytes to 4aPDD are significantly augmented. Collectively, we show that TRPV4 channels are involved in ischemia-
induced calcium entry in reactive astrocytes and thus, might participate in the pathogenic mechanisms of astroglial
reactivity following ischemic insult.
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Introduction
During pathological conditions such as cerebral ischemia, a
rapid increase of intracellular calcium ([Ca
2+]i) initiates dramatic
changes in the nervous tissue, leading to apoptotic and necrotic
cell death and reactive gliosis [1,2]. There is considerable evidence
that the [Ca
2+]i oscillations and propagating [Ca
2+]i waves evoked
by focal ischemia can spread through the astroglial syncytium for a
long distance and cause damage in distal CNS regions [3]. Despite
the large number of studies describing the phenomenon of
astroglial calcium influx evoked by acute brain injury, data
regarding the molecular identity of the ion channels and receptors
involved in this event are more elusive. It has been suggested that
in astrocytes the massive and uncontrolled plasmalemal Ca
2+ entry
after hypoxia/ischemia could be mediated by the activation of
voltage-gated Ca
2+ channels [4], NMDA receptors [5], P2X7 and
P2Y purinergic receptors [6], the reversed operation of the Na/
Ca
2+ exchanger [7] and potentially, Ca
2+ permeable cation
channels such as transient receptor potential (TRP) channels [8].
Previously, it has been shown that in the brain TRP channels are
expressed predominantly in neurons. Lipski and co-workers [9]
have demonstrated the expression of TRPM2/TRPM7 and
TRPV3/TRPV4 in neurons of the CA1 subfield of the
hippocampus and suggested their involvement in oxidative stress.
Furthermore, Cao and co-authors [10] revealed the co-expression
of TRPV1 and TRPV4 in neuronal cell bodies of the dorsal root
ganglion (DRG) and found that 4-alpha-phorbol 12, 13-didecano-
ate (4aPDD) induced an increase of [Ca
2+]i in DRG neuronal co-
cultures. The expression of different TRP channels was also
described in glial cells. Numerous investigators have demonstrated
the expression of heteromultimeric complexes of TRPC1-,
TRPC3-, TRPC4- and TRPC5 channels in embryonic cultured
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as their involvement in the modulation of store-operated Ca
2+
entry activity [11–13].
Of particular interest is a member of the vanilloid subfamily, the
TRPV4 channel, which is widely expressed in the brain [14].
TRPV4 channels can be activated by diverse stimuli such as
moderate heat, endogenous agonists such as arachidonic acid or
the synthetic ligand 4aPDD [15–17]. In astrocytes, TRPV4 is also
sensitive to hypotonicity, and by forming a molecular complex
with aquaporins, it might participate in regulating cell volume
recovery [18–20]. There is evidence that primary cultured
astrocytes as well as cortical astrocytes of the rat neocortex
strongly express TRPV4 channels [21]. Typical TRPV4 currents
activated by 4aPDD or hypotonicity and blocked by Ca
2+-free
solution or the TRPV4 inhibitor, Ruthenium Red (RR) have been
found in cultured astrocytes. A recent study on organotypic slices
of the juvenile hippocampus confirmed TRPV4 channel expres-
sion in astrocytes and revealed their involvement in oxidative
stress-induced cell death [8]. The application of RR or Gd
3+
reduced astrocytic damage, thus suggesting the involvement of
TRPV4 channels in astroglial pathophysiology. However, to the
best of our knowledge, the role of astrocytic TRPV4 channels
during in vivo ischemic injury has not yet been defined.
The present study was undertaken to address the pathophys-
iological role of TRPV4 channels in adult rat astrocytes. The
functional expression of TRPV4 channels in hippocampal
astrocytes was investigated after the induction of cerebral
hypoxia/ischemia (H/I) by a bilateral occlusion of the carotids
combined with hypoxic conditions and followed by reperfusion. By
using immunocyto/histochemical and western blot analyses, as
well as single cell microfluorimetry and electrophysiological
techniques, we have characterized TRPV4 expression in sham-
operated rats and those 1 hour after H/I (acute phase of
reperfusion) and 7 days after H/I (late phase of reperfusion). We
show that TRPV4 expression and activity are up-regulated in
astrocytes following ischemia, suggesting that this channel could be
involved in the [Ca
2+]i elevation occurring in the astroglial
syncytium as a result of an ischemic insult.
Materials and Methods
Ethics Statement
All procedures involving the use of laboratory animals were
performed in accordance with the European Communities
Council Directive 24 November 1986 (86/609/EEC) and animal
care guidelines approved by the Institute of Experimental
Medicine, Academy of Sciences of the Czech Republic Animal
Care Committee on April 17, 2009; approval number 85/2009.
Induction of Cerebral Hypoxia/ischemia in Rats
Adult male Wistar rats (200 to 250 g) were pre-medicated with
atropine (100 mg/kg, s.c.; Biotika, Slovak Republic) and anesthe-
tized with sodium pentobarbital (PTB, 65 mg/kg, i.p.; Sigma-
Aldrich, St. Louis, MO, USA). Hypoxia/ischemia was induced by
a bilateral 15-minute occlusion of the common carotids combined
with hypoxic conditions as described previously [22,23]. The rats
were intubated by a cannula tube (Abbocath-T 16G, Abbott,
Sligo, Ireland) and mechanically ventilated with 33.3% O2 and
66.6% N2 (rate 60 cycles/min, Linde Gas, Prague, Czech Rep.)
using a CIV-101 animal ventilator (Columbus Instruments,
Columbus, OH, USA) for 15 minutes prior to carotid artery
occlusion and during the first 60 minutes of reperfusion. Body
temperature was controlled with a heating pad and maintained at
3761uC throughout the surgery. Both carotid arteries were
exposed and occluded with aneurism clips for 15 minutes. During
the occlusion the rats were ventilated with 6% O2 and 94% N2
(Linde Gas, Prague, Czech Rep.). After 15 minutes of H/I the
clamps were removed and the blood flow was renewed. In sham-
operated rats, which were used as a control, the common carotid
arteries were exposed but not occluded. The rats were left to
survive for 1 hour (1H H/I) or 7 days after hypoxia/ischemia (7D
H/I). The animals were housed individually and allowed food and
water ad libitum.
Acute Brain Slice Preparation for Electrophysiology
After the reperfusion period the rats were deeply anesthetized
with a sub-lethal dose of PTB (100 mg/kg, i.p.) and perfused
transcardially with cold (4uC, 40 ml) isolation solution containing
(in mM): 110 NMDG-Cl, 2.5 KCl, 24.5 NaHCO3, 1.25
Na2HPO4, 0.5 CaCl2, 7 MgCl2, 20 glucose (pH 7.4, osmolality
290 mOsm/kg). After decapitation, the brains were quickly
dissected out and fixed on a cutting disk using 3 M Vetbond
tissue adhesive (World Precision Instruments, Sarasota, FL, USA).
Then the brains were transferred to a microtome chamber
containing cold (4uC) isolation solution gassed with 95% O2 and
5% CO2. Transversal 220 mm thick slices were cut using an HM
650 V vibration microtome (Thermo Scientific Microm, Walldorf,
Germany). Subsequently, the slices were incubated in isolation
solution (34uC) for 30 minutes and then kept in artificial
cerebrospinal fluid, further termed aCSF (see Table 1), at room
temperature for at least 1 hour.
Preparation of Primary Cultures of Dissociated Astrocytes
from the CA1 Region of the Hippocampus
Primary cultured astrocytes were prepared from all experimen-
tal groups of rats: sham-operated rats and those 1 hour and 7 days
after hypoxia/ischemia. Transcardial perfusion and slice prepara-
tion were performed as described above, while the thickness of the
coronal slices was 700 mm. The hippocampal CA1 region was
dissected out from the slice, cut into small pieces and transferred
into a Falcon tube with 4 ml of Dubelcco’s Modified Eagle
Medium (DMEM, Gibco-Invitrogen, Carlsbad, CA, USA) con-
taining 15% fetal bovine serum (FBS, PAA Laboratories GmbH,
Pasching, Austria), then centrifuged for 3 minutes at 2000 rpm.
The supernatant was discarded and the tissue was dissociated by a
micropipette in 2 ml of solution containing 0.05% Trypsin and
2 g/l ethylene-diamine-tetraacetic acid (EDTA, Sigma-Aldrich,
St. Louis, MO, USA). After 3 minutes, the dissociated cells were
transferred into Falcon tubes containing 2 ml of FBS solution to
block the trypsinization. After centrifugation (3 min at 2000 rpm),
the supernatant was removed and fresh cultivation medium
(DMEM containing 15% FBS) was added up to 6 ml. The cells
were resuspended and plated in 0.5 ml volumes onto 12 poly-L-
lysine (PLL, Sigma-Aldrich, St. Louis, MO, USA)-coated cover-
slips. Cells were cultured in DMEM containing 15% FBS in an
incubator (100% humidity, 5% CO2)a t3 7 uC with medium
exchange on the fourth day. After 4–5 days the cells were used for
immunocytochemistry, patch-clamp and [Ca
2+]i measurements.
Solutions and Reagents
Solutions. Various extracellular and intracellular solutions
were used in our experiments and they are listed in Table 1.
For microfluorimetric analyses of intracellular calcium ([Ca
2+]i)
in vitro and in situ, the extracellular solutions aCSF and aCSFØCa
were used. For the electrophysiological characterization of
astrocytes in situ and in vitro, the extracellular solution aCSF and
the intracellular solution Int1 were used, whereas recordings for
TRPV4 Channels in Astrocytes after Ischemia
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extracellular solution Ext1 and the intracellular solution Int2 as
previously described by Benfenati and co-authors [21]. In order to
facilitate the isolation of TRPV4 currents, Na
+ and K
+ conduc-




extracellular (Ext2) and intracellular solutions (Int2). In the
intracellular solution, Cl
- was partially replaced by gluconate to
diminish the activation of astroglial Cl
- conductance [24]. All
chemicals were purchased from Sigma-Aldrich, St. Louis, MO,
USA.
Agonists and antagonists. The TRPV4 activator 4-alpha-
phorbol 12, 13-didecanoate (4aPDD, Sigma-Aldrich, St. Louis,
MO, USA) was applied at 5 mM for in vitro and 5–10 mM for in situ
studies. Cells were exposed to 4aPDD for 6–8 min. 4aPDD was
kept in aliquots at 220uC in dimethyl sulfoxide (DMSO, Sigma-
Aldrich, St. Louis, MO, USA). Aliquots of Ruthenium Red (RR,
Sigma-Aldrich, St. Louis, MO, USA) and RN1734 (Tocris
Bioscience, Bristol, UK) were also prepared in DMSO. Aliquots
were stored at 220uC, and the solutions were prepared
immediately before use (the final concentration of DMSO was
less than 0.03%).
Patch-clamp Recording
Membrane currents were recorded using the patch-clamp
technique in the whole-cell configuration in slices as well as in
primary cultured astrocytes. Recording pipettes with a tip
resistance of 8–12 MV were made from borosilicate capillaries
(0.86 ID, Sutter Instruments Company, Novato, CA, USA) using
a P-97 Brown-Flaming micropipette puller (Sutter Instruments,
Novato, CA, USA). To visualize the recorded cells, the
intracellular solution contained either Lucifer Yellow (LY,
Sigma-Aldrich, St. Louis, MO, USA) or Alexa-Fluor hydrazide
488/594 (Molecular Probes, Carlsbad, CA, USA). The LY-labeled
cells were used for further post-recording immunocytochemical
identification. Since TRPV4 is a moderately heat sensitive channel
[16], the electrophysiological experiments were performed at
2862uC. Electrophysiological data were measured with 10 kHz
sample frequency using an EPC10 amplifier controlled by TIDA
or PatchMaster software (HEKA Elektronik, Lambrecht/Pfalz,
Germany) and were filtered at 2.9 kHz using a Bessel filter. Acute
brain slices or coverslips with primary astrocyte cultures were
transferred to the recording chamber of an upright Axioscop
microscope (Zeiss, Gottingen, Germany) equipped with electronic
micromanipulators (Luigs &Neumann, Ratingen, Germany) and a
high-resolution AxioCam HRc digital camera (Zeiss, Germany).
Resting membrane potential (Vrest) and membrane capacitance
(Cm) were measured as described previously [25]. Input resistance
(IR) was determined from the currents evoked by membrane
depolarization from 270 mV to 260 mV, 40 ms after the onset
of depolarization. Electrophysiological data were analyzed using
TIDA and Fitmaster software (HEKA, Lambrecht, Germany).
Recorded membrane potentials were corrected for the liquid
junction potential using JPCALCW software [26].
Microfluorimetric Analysis of Intracellular Calcium Levels
Coverslips with 4–5-day-old cell cultures were incubated for 1
hour in 1.5 ml DMEM +15% FBS medium containing 3.3 mM
Fluo-4 AM and 0.07% Pluronic F-127 (Invitrogen, Carlsbad, CA,
USA) at 37uC in an incubator (100% humidity, 5% CO2). The
coverslips were then transferred to a microscope superfusion
chamber, and two measurements were made on each coverslip
with a sufficient distance between the measurement regions. After
the measurements, immunocytochemical staining for GFAP was
performed to confirm the astrocytic identity of the measured cells.
In situ measurements were performed in the stratum radiatum of
the CA1 region of the hippocampus, 10–20 mm below the surface
of the slice. As already described, 220 mm thick transversal brain
slices were cut in 4uC isolation solution using a vibration
microtome. They were then incubated for 20 min in isolation
solution gassed with 95% O2 and 5% CO2 containing 1 mM
Table 1. Composition of the extracellular and intracellular solutions for Ca
2+ imaging and patch-clamp measurements.
Extracellular solutions used for [Ca
2+]i measurements in vitro and in situ
NaCl KCl MgCl2 CaCl2 NaHCO3 Na2HPO4 Glucose mOsm/kg
aCSF 122 3 1.3 1.5 28 1.25 10 30565
aCSFØCa 122 3 1.3 – 28 1.25 10 30565
Extracellular solutions used for whole-cell patch-clamp recordings in vitro and in situ
NaCl KCl MgCl CaCl2 HEPES CsCl Glucose mOsm/kg pH
Ext1 1 4 0 4 221 0 – 5 3 1 5 65 NaOH
Ext2 – – 2 10 10 122 5 31565 CsOH
Ext2ØCa – – 2 – 10 122 5 31565 CsOH
Intracellular solutions used for whole-cell patch-clamp recordings in vitro and in situ
CsGluc CsCl KCl CaCl2 MgCl2 EGTA HEPES mOsm/kg pH
Int1 – – 130 0.5 2 5 10 28065 KOH
Int2 1 0 0 2 6 ––2 1 1 03 0 0 65 CsOH
Abbreviations: extracellular solution (Ext); intracellular solution (Int). All concentrations are in mM. The pH of the extracellular solutions was adjusted to 7.4 with NaOH in
Ext1 or with CsOH in Ext2 and Ext2ØCa, while the pH of the intracellular solutions was adjusted to 7.2 with KOH in Int1 or CsOH in Int2. Osmolality was adjusted with
mannitol in Ext1, Ext2, Ext2ØCa and Int1 solutions.
doi:10.1371/journal.pone.0039959.t001
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USA) at 34uC. The slices were then placed onto a nylon mesh
in a dish (3 ml volume) and incubated for 60 min in aCSF
containing 4 mM Fluo-4 AM and 0.01% Pluronic F-127 at room
temperature. During incubation, the dish was in a dark
environment and gassed with 95% O2 and 5% CO2. The slices
were then mounted on a microscope superfusion chamber, and
two measurements were performed with a sufficient distance
between them. For verification that the measured cells were
astrocytes, SR-101 staining was used since this fluorescent dye is
preferentially taken up by astrocytes [27].
During the measurements, the microscope superfusion chamber
was continually perfused with aCSF at a flow rate of 2.5 ml/min.
The temperature was held at 2862uC throughout the experiments
by a ThermoClamp-1 (AutoMate Scientific, Inc. Berkeley, CA,
USA). The solutions were applied through a capillary (i.d. 250 mm)
located 0.5–1 mm from the measurement region and connected to
a Perfusion Pressure Kit pressurized application system (flow rate
600 ml/min) controlled by a ValveBank II controller (AutoMate
Scientific, Inc. Berkeley, CA, USA). Since TRPV4 channels are
stretch-sensitive [28], aCSF was applied before and after 4aPDD
application with the same flow rate to verify that the response was
not influenced by the application itself. Fluo-4 fluorescence was
detected with a TILL Photonics Imaging System installed on a
Zeiss Axioskop 2 FS Plus microscope equipped with a long-
distance 106objective (Achroplan 0.3 W, Ph 1, Zeiss, Germany)
for measurements in vitro or a long-distance 406 objective (IR
Achroplan 0.8 W, Zeiss, Germany) for measurements in situ.A
digital camera (PCO Sensicam, Kelheim, Germany) was con-
trolled by TILLvisION software. The excitation light (488 nm)
was generated by a Polychrome V (TILL Photonics GmbH,
Gra ¨felfing, Germany), filtered by a BP 450–490 excitation band-
pass filter, reflected by a FT 510 beam splitter and the emitted
light was filtered by a LP 515 long-pass filter (Filter Set 09, Zeiss,
Germany). Images were acquired at 0.83 Hz and were analyzed
offline. Fluorescence intensity (F) was measured in the cell bodies
and expressed as (F2F0)/F0 after background correction, where F0
is the baseline fluorescence intensity before drug application. The
threshold for a Ca
2+ response in vitro was 120% of F0, and the
threshold amplitude for a transient peak in situ was 200% of the
amplitude of the noise signal. The excitation light for SR-101
(570 nm) was filtered by a BP565/30 band-pass filter, reflected by
a FT585 beam splitter and the emitted light was filtered by a 620/
60 band-pass filter (Filter Set 31, Zeiss, Germany).
Immunocytochemistry/Immunohistochemistry
Primary cultured astrocytes attached to PLL-coated coverslips were
fixed on the 4–5th day of culture in 4% paraformaldehyde solution
in 0.2 M phosphate buffer (PB, pH 7.4) for 8 minutes and kept in
10 mM phosphate buffered saline (PBS) at 4uC for further
processing. Coverslips were incubated in a blocking solution
containing 5% Chemiblocker (Millipore, Billerica, MA, USA) and
0.5% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) in
10 mM PBS at 4uC for two hours. They were then incubated
overnight at 4uC with a rabbit anti-TRPV4 antibody (1:200;
Novus Biologicals, Littleton, CO, USA) in PBS containing 0.2%
Triton X-100. After overnight incubation, three 10-min washes
with PBS were performed, followed by incubation with Alexa 488-
conjugated goat anti-rabbit IgG- (1:200; GAR-488, Molecular
Probes, Carlsbad, CA, USA) for two hours at 4uC. For double
labeling, a mouse monoclonal antibody directed against GFAP
and conjugated with Cy3 (1:800; Sigma-Aldrich, St. Louis, MO,
USA) was subsequently applied and incubated overnight at 4uC.
Afterwards, the coverslips were washed in PBS three times for 10
minutes each. To visualize the cell nuclei, the coverslips were
incubated with 300 nM 49,6-diamidino-2-phenylindole (DAPI) in
PBS for 5 minutes at room temperature. Finally, the coverslips
were mounted using Aqua Poly/Mount (Polysciences Inc.,
Eppelheim, Germany).
Brain slices were prepared from control rats and those 1H and
7D after H/I. Animals were anesthetized with a sub-lethal dose of
PTB (100 mg/kg, i.p.) and perfused transcardially with 70 ml of
0.9% saline with heparin (2500 IU/100 ml), (Zentiva, Prague,
Czech Republic), followed by 70 ml of 4% paraformaldehyde
solution in PBS (PFA/PBS). Dissected brains were postfixed
overnight in 4% PFA/PBS, cryoprotected for several hours in a
series of 10%, 20% and 30% sucrose in 0.2 M PB, then sectioned
in the coronal plane (30 mm thickness). To enhance the efficiency
of immunostaining the sections were incubated for 20 minutes in
citrate buffer (10 mM Citric Acid, 0.05% Tween 20 in PB,
pH 6.0) at 80uC. After washout in PB, the sections were further
incubated in a blocking solution containing 2% normal goat serum
(NGS, Millipore, Billerica, MA, USA), 5% Chemiblocker, 1%
bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO, USA)
and 0.5% Triton X-100 in PB for 2 hours at 4uC. An epitope-
specific rabbit anti-TRPV4 (1:500) and Cy3-conjugated mouse
anti-GFAP (1:800) were diluted in 5% Chemiblocker and
incubated with the sections overnight at 4uC. After incubation,
three 10-min washes with PBS removed the unbound antibodies.
Alexa 488-conjugated goat anti-rabbit IgG (1:200) (GAR-488,
Invitrogen/Molecular Probes, Carlsbad, CA, USA) was applied
and the slices were incubated for two hours at 4uC. Slices were
then washed in PBS and mounted with Vectashield containing
DAPI (Vector Laboratories, Burlingame, CA) for visualization of
the nuclei. For immunohistochemical analysis of the hippocampus
after hypoxia/ischemia, mouse anti-NeuN (1:100; Millipore,
Billerica, MA, USA) and Cy3-conjugated mouse anti-GFAP
(1:800) primary antibodies were used. For cell identification after
patch-clamp recording, the measured cells were filled either with
Alexa Fluor 488 hydrazide or LY by dialyzing the cytoplasm with
the patch pipette solution. Post-recording, the coverslips and slices
were fixed with 4% PFA in 100 mM PB for 8 min or 1 hour,
respectively. After incubation in a blocking solution containing 5%
Chemiblocker and 0.5% Triton X-100 in 10 mM PBS, Cy3-
conjugated mouse anti-GFAP (1:800) was applied for 2 hours at
4uC. The specificity of the TRPV4 staining was confirmed by
strong TRPV4 immunostaining in the choroid plexus, as described
previously [8,16]. The slices/coverslips were then examined using
an LSM 5 DUO spectral confocal microscope (Zeiss, Germany).
Western Blotting
Hippocampal samples for Western blot analysis were isolated
from rats after H/I (1H, 6H, 1D, 3D, 7D), sham-operated animals
(6H, 3D) or intact animals. Rats were deeply anesthetized with
PTB (100 mg/kg, i.p.), perfused transcardially with chilled
isolation solution and decapitated. The brains were dissected out
and cut into 500 mm thick slices. The CA1 region of the
hippocampus was excised from each slice and homogenized using
an ultrasound homogenizator in Tris buffer (pH 6.8) containing
10% glycerol and 1% sodium dodecyl sulphate (SDS). Total
protein content in the homogenates was determined by the Micro
BCA
TM protein assay kit (ThermoFisherScientific, Rockford, IL,
USA). Tissue homogenates were heated at 100uC for 5 minutes
with 0.5% dithiothreitol. Equal amounts of proteins were
separated on a 6% SDS-polyacrylamide gel (for TRPV4 protein)
or 10% SDS-polyacrylamide gel (for GFAP and b-actin) and
subsequently electrotransferred to a nitrocellulose membrane using
a TE 70XP Semi-Dry Transfer unit (Hoefer, Holliston, MA,
TRPV4 Channels in Astrocytes after Ischemia
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PBS–Tween buffer (0.05% Tween) for 1 hour at room temper-
ature. The incubation with the primary antibodies diluted in PBS
containing 1% non-fat dry milk, 0.05% Tween and 0.1% NaN3
was performed at 4uC overnight, followed by a 2 hour incubation
with goat anti-rabbit IgG conjugated with peroxidase (Sigma–
Aldrich, St. Louis, MO, USA) at room temperature. The following
primary antibodies were used: rabbit anti-GFAP (1:600, Sigma–
Aldrich, St. Louis, MO, USA), rabbit anti-TRPV4 (1:300;
Alomone Labs, Jerusalem, Israel) and rabbit anti-b-actin (Abcam,
Cambridge, UK). SuperSignal West Pico Chemiluminiscent
Substrate (Thermo Fisher Scientific, Rockford, IL, USA) was
used to develop the Western blots. To quantify the changes in
TRPV4 protein content, Quantity One software (Bio-Rad
Laboratories, Hercules, CA, USA) was employed for imaging
and analyzing 1-D electrophoresis gels. Quantification was carried
out using 3 independent Western blot analyses (Fig. S1).
Quantitative PCR Analyses
The hippocampal CA1 regions from 3 sham-operated and 3
ischemic rats (1H after H/I) were immediately placed into RLT
buffer after dissection (Qiagen, Gemany). Total RNA was
extracted using an RNeasy Mini Kit, including DNase treatment
(Qiagen, Germany). RNA concentrations were measured with a
NanoDrop ND-1000 spectrophotometer (Nanodrop Technolo-
gies). Using SuperScript III (Life Technologies), reverse transcrip-
tion was performed as described recently [29]. Real-time PCR
measurements were performed using a Biorad CFX (Bio-Rad
Laboratories, Hercules, CA, USA) and a temperature profile of
95uC for 3 minutes, followed by 40 cycles at 95uC for 15 s, 60uC
for 15 s, and 72uC for 20 s. The ten-microliter reactions contained
iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA,
USA) and 400 nM of each primer (Metabion, Germany). The
employed primer sequences were: Trpv4_forward:
TTTGCTCTTATTTCTACTCCTCCC and Trpv4_reverse:
GCTGGCTTAGGTGACTCC. Reference genes were evaluated
using the Mouse Endogenous Control Gene Panel (TATAA
Biocenter, Sweden) and NormFinder. All data were normalized
against b2-microtubulin (B2M). Relative changes in expression
were calculated using the DDCq Method [30].
Data Analysis and Statistics
Data are presented as means 6 S.E.M. (standard error of the
mean) for n cells. Student’s unpaired t-test or one-way ANOVA for
multiple comparisons were used to determine significant differ-
ences between the experimental groups. Values of *p,0.05 were
considered significant, **p,0.01 very significant and *** p,0.001
extremely significant.
Results
Increased TRPV4 Immunoreactivity in Hippocampal
Astrocytes Coincides with the Development of
Astrogliosis
To investigate the expression of TRPV4 channels in astrocytes
and their possible contribution to hypoxia/ischemia-induced
astroglial reactivity, we performed immunohistochemical analyses
of the rat hippocampus in control and ischemic rats (Fig. 1A, B).
As previously described by Anderova and co-authors [22],
hypoxic/ischemic injury was characterized by a decrease in NeuN
immunoreactivity due to neuronal loss occurring within 3–7 days
after hypoxia/ischemia (H/I) and by an increase in GFAP
immunoreactivity due to the development of astrogliosis within
7D after H/I (Fig. 1A). In control hippocampal sections double
immunostaining with antibodies against TRPV4 and GFAP
revealed neuronal TRPV4 immunoreactivity in the stratum pyrami-
dale of the CA1 region and only a few TRPV4-positive astrocytes
in the stratum radiatum of controls (Fig. 1B). However, TRPV4
immunoreactivity gradually increased in astrocytes with the
progression of reactive gliosis in response to H/I, and it declined
in CA1 pyramidal neurons in conjunction with ongoing neuronal
cell death. Within 7 days of reperfusion we have observed a shift in
TRPV4 immunoreactivity from neurons to reactive astrocytes
(data not shown), leading to TRPV4 expression only in reactive
astrocytes (Fig. 1B). No pyramidal cells positive for TRPV4 were
found in the CA1 hippocampal region after 7 days of reperfusion.
To verify the molecular expression of TRPV4 after H/I, we
performed Western blot analyses of protein lysates extracted from
the CA1 region of the hippocampus in control rats and those 1
hour (1H), 6 hours (6H), 1 day (1D), 3 days (3D) and 7 days (7D)
after H/I. TRPV4-positive bands of molecular weight ,120 kDa
were detected with an increase in TRPV4 protein levels 1H after
H/I, while 1D and 7D after H/I the overall expression of TRPV4
was down-regulated (Fig. 2 and Fig. S1). Additionally,
quantitative real-time PCR analyses revealed that there was a
2.4-fold increase in TRPV4 mRNA 1 hour after H/I when
compared to the mRNA content of the hippocampal CA1 region
in sham-operated rats (Fig. 2). As expected for an increase in
astroglial reactivity, GFAP was gradually increased 3D and 7D
after ischemia (Fig. 2 and Fig. S1). The apparent discrepancy in
TRPV4 expression between immunocytochemistry and Western
blotting could be due to the fact that following H/I, neuronal
viability decreases, and this could account for the overall decrease
in TRPV4 protein levels observed in total cell lysates of the
hippocampal CA1 region.
TRPV4-mediated Responses in Reactive Astrocytes are
Augmented in Situ after Hypoxia/ischemia
Having demonstrated that TRPV4 expression in astrocytes
increases in response to H/I, we next sought to elucidate the
impact of ischemic injury on TRPV4 channel activity in astrocytes
Figure 1. Immunohistochemical analyses of the rat hippocampus after hypoxia/ischemia followed by reperfusion. (A) Coronal
sections of the rat hippocampus immunostained for a neuronal marker (NeuN) and the astrocytic marker glial fibrillary acidic protein (GFAP) in sham-
operated rats (CTRL) and those 7 days (7D) after hypoxia/ischemia (H/I). Enlargements of the tissue section shown on the right demonstrate
pyramidal cell loss and the formation of reactive gliosis in the hippocampal CA1 region 7D after H/I when compared to controls. (B) TRPV4
immunostaining in the CA1 region of the hippocampus. Coronal slices from controls and ischemic rats were labeled for TRPV4 (green) and GFAP (red).
Note that in controls the TRPV4 immunoreactivity was detected in pyramidal cells and more rarely in astrocytes. With developing astrogliosis TRPV4
immunoreactivity was increased in astrocytes. Seven days after H/I no TRPV4 expression was detected in pyramidal cells, whereas it was markedly
increased in astrocytes. The following abbreviations are used: H/I (hypoxia/ischemia), CTRL (sham-operated rats), 1H (1 hour), 7D (7 days) after
hypoxia/ischemia, s.p. (stratum pyramidale), s.r. (stratum radiatum).
doi:10.1371/journal.pone.0039959.g001
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[Ca
2+]i signals. Typical images of microfluorimetric [Ca
2+]i
measurements of astrocytes in situ are shown in Figure 3 A-D.
Spontaneous transient [Ca
2+]i spikes measured in aCSF were
typically observed in astrocytes from non-ischemic rats (Fig. 3F,
blue trace, CTRL, n=35). The oscillation frequency of these
spontaneous transient Ca
2+ spikes significantly increased with the
time of reperfusion (Fig. 3F, 1H after H/I - green trace, n=27;
7D after H/I - red trace, n=30), with a ,20-fold increase in
astrocytes 7D after H/I when compared to controls (Fig. 3G).
The subsequent application of 5 mM4 aPDD, a selective TRPV4
agonist [31], resulted in an additional increase in spike frequency
(Fig. 3G). In a few astrocytes 1H after H/I and in most of the
astrocytes 7D after H/I, 4aPDD evoked an increase in the
amplitude of the [Ca
2+]i signals (Fig. 3F). Although initially
4aPDD application evoked [Ca
2+]i oscillations similar to those
observed in astrocytes of controls or those 1H after H/I, in
astrocytes 7D after H/I prolonged exposure to 4aPDD resulted in
the generation of sustained Ca
2+ entry. The application of 4aPDD
in the absence of extracellular Ca
2+ (aCSFØCa) immediately and
almost completely abolished the Ca
2+ spike activity, which was
restored upon re-addition of Ca
2+. During washout, in some of the
astrocytes 7D after H/I, the elevated signal amplitude was
restored, but distinct spikes were no longer detectable. The
application of 5 mM4 aPDD in the presence of 10 mM RN1734, a
novel TRPV4 inhibitor [32], abolished ,70% of the Ca
2+ spike
activity in astrocytes 7D after H/I, which was not restored after
washout in aCSF (Fig. 4). We also found that 7D after H/I the
spontaneous Ca
2+ transients are partly mediated by TRPV4
channels as the application of RN1734 blocked ,45% of such
spontaneous Ca
2+ transients(Fig. 4C). Interestingly, 7 days after
H/I 4aPDD not only increased spontaneous Ca
2+ transients, but
also resulted in sustained Ca
2+ entry as demonstrated in Fig. 3F
(red line), represented by an increase in the baseline fluorescence
intensity. Such sustained Ca
2+ entry, which was always completely
blocked in the absence of extracellular Ca
2+, was rare in controls
(1cell out of 35); however, it increased with the time of reperfusion:
it was detected in 4 cells out of 27 1H after H/I and in17 cells out
of 30 7D after H/I. Surprisingly, RN1734 blocked only Ca
2+
transients; we never observed a decline of sustained Ca
2+ entry in
response to this inhibitor (Fig. 4A, red line). The incidence of
4aPDD-specific responses increased in post-ischemic astrocytes;
only 56% of astrocytes from controls exhibited a 4aPDD-evoked
increase in [Ca
2+]i, oscillations, while 78% and 84% of astrocytes
responded to 4aPDD application 1 hour and 7 days after H/I,
respectively. These results indicate that the increased expression/
immunoreactivity of TRPV4 in ischemic astrocytes is accompa-
nied by enhanced TRPV4-mediated Ca
2+ oscillations.
Next, we examined the effect of H/I on TRPV4-mediated
currents in astrocytes in situ. The typical membrane current
patterns of hippocampal astrocytes in control and ischemic tissue
were identified in Ext1 by hyper- and depolarizing the astrocytic
membrane from 2100 mV to +100 mV in 20 mV increments,
with the holding potential (Vh)a t270 mV (Fig. 5A). Generally,
the mature hippocampal astrocytes displayed a passive current
pattern, characterized by time- and voltage-independent currents,
Figure 2. Western blot and PCR analyses of TRPV4 protein in
the CA1 region of the hippocampus after hypoxia/ischemia. (A)
Time-dependent changes in the expression of TRPV4, GFAP and b-actin
proteins in the CA1 region of the hippocampus of sham-operated rats
(CTRL), 1 hour (1H), 6 hours (6H), 1 day (1D), 3 days (3D) and 7 days (7D)
after hypoxia/ischemia. Note that the expression of GFAP gradually
increased 3 and 7 days after ischemia. b-actin was used as a loading
control. (B) Time-dependent changes in TRPV4 protein levels showing
the significant increase in TRPV4 protein 1H after H/I. Data were
obtained from 3 independent Western blot analyses. (C) Quantitative
RT-PCR revealing significantly increased TRPV4 mRNA levels 1H after H/I
compared to sham-operated rats. Data were obtained from 3
independent isolations of total mRNA from the hippocampal CA1
region. Statistical significance was calculated using one-way ANOVA
and Dunnett’s multiple comparison test; *p,0.05 significant, **p,0.01
very significant.
doi:10.1371/journal.pone.0039959.g002
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39959Figure 3. The TRPV4 agonist 4aPDD triggers Ca
2+ oscillations in astrocytes of the hippocampal CA1 region. (A–D) Astrocytes in acute
rat hippocampal slices loaded with the calcium fluorescent probe Fluo-4 AM respond with an increase in fluorescence to the application of the TRPV4
channel agonist 4aPDD (5 mM). (A) Cells before 4aPDD application in aCSF, (B) during 4aPDD application, (C) during 4aPDD application in aCSF
without Ca
2+ (aCSFØCa) and (D) during washout with aCSF. Note the increased fluorescence indicated by the arrow in B. (E) Cells loaded with
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+ channels, and their passive membrane
properties are listed in Table 2. In agreement with our previously
published data [23], the CA1 hippocampal astrocytes were slightly
depolarized 7 days after H/I. To isolate more accurately the
TRPV4-specific cationic currents, further recordings were per-
formed in intra- and extracellular solutions in which K
+ and Na
+
were replaced with Cs
+ [21]. Under these experimental conditions,
membrane currents evoked by hyperpolarizing and depolarizing
voltage steps from 2100 mV to +100 mV (at Vh of 240 mV)
were diminished (Fig. 5A). To elicit TRPV4-mediated currents,
astrocytes in situ were recorded in Ext2 solution and 10 mM
4aPDD was applied for 6–8 minutes. The cells were clamped at
Vh of 0 mV and stimulated with a voltage ramp from 2100 mV
to +100 mV (500 ms) after a 500 ms potential step to 2100 mV.
Sulforhodamine 101 (SR-101) to verify that the measured cells are astrocytes. (F) Representative fluorescence traces with background correction of
astrocytes in acute slices prepared from sham-operated rats (CTRL) and rats 1 hour (1H H/I) and 7 days (7D H/I) after hypoxia/ischemia. (G) Histogram
of the mean intracellular calcium transients per hour before 4aPDD application (aCSF), during 4aPDD application (4aPDD), during 4aPDD application
in aCSFØCa (4aPDD in aCSFØCa) and following washout (aCSF), measured in astrocytes from acute hippocampal slices prepared from the brains of
sham-operated rats (CRTL) and those 1 hour (1H H/I) and 7 days (7D H/I) after hypoxia/ischemia. (H) Histogram of the number of responding cells
(n= number of all analyzed cells). The values are presented as mean 6 S.E.M. Statistical significance was calculated using one-way ANOVA. *p,0.05,
significant; ***p,0.001, extremely significant.
doi:10.1371/journal.pone.0039959.g003
Figure 4. The TRPV4 antagonist RN1734 decreases 4aPDD-induced and spontaneous Ca
2+ oscillations in astrocytes of the
hippocampal CA1 region 7 days after ischemia. (A) Representative fluorescence traces of hippocampal astrocytes in slices prepared from
sham-operated rats (CTRL) and rats 7 days after hypoxia/ischemia (7D H/I) before 4aPDD application (aCSF), during 5 mM4 aPDD application, during
the application of 5 mM4 aPDD with 10 mM RN1734 and following washout (aCSF). (B) Histogram of the mean intracellular calcium transients per hour
before 4aPDD application (aCSF), during the application of 5 mM4 aPDD, during the application of 5 mM4 aPDD +10 mM RN1734 and following
washout in aCSF, in astrocytes in hippocampal slices prepared from the brains of sham-operated rats (CRTL, n=43) and those 7 days after hypoxia/
ischemia (7D H/I, n=40). (C) Histogram of the mean spontaneous intracellular calcium transients per hour before RN1734 application (aCSF) and
during the application of 10 mM RN1734 (RN1734), measured in astrocytes from acute hippocampal slices 7 days after hypoxia/ischemia (7D H/I,
n=10). The values are presented as mean 6 S.E.M. Statistical significance was calculated using one-way ANOVA in (B) and a paired t-test in (C);
***p,0.001 extremely significant, **p,0.01 very significant.
doi:10.1371/journal.pone.0039959.g004
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PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39959Only 25% of astrocytes from controls exhibited 4aPDD-evoked
currents, whereas the incidence of responding astrocytes increased
1H (52%) and 7D (59%) after H/I (Fig. 5B). The threshold for a
4aPDD current response was 120% of the control ramp current
(prior to agonist application), at a voltage of +/2100 mV. In
response to 4aPDD application, astrocytes exhibited an increase in
outward and inward currents (Fig. 5C), delayed 1–3 minutes after
the onset of agonist application, with a rather linear current-
voltage relationship (Fig. 5D). Nevertheless, the 4aPDD-evoked
current amplitudes were not significantly different when compared
to those in control astrocytes or those recorded after H/I (Fig.
S2). Exposure to 4aPDD shifted the reversal potential from
215.162.2 mV to 25.961.7 mV (DErev =9.161.7 mV, n=13),
which is consistent with the development of a cationic current. In
the absence of extracellular Ca
2+ (Ext2ØCa), the amplitude of the
4aPDD–evoked currents was reduced by 68.7618.3% (n=4,
Fig. 6A). Finally, the extracellular application of the non-specific
inhibitor of TRP channels Ruthenium Red (RR, 10 mM) [33] or
RN1734 (10 mM) reduced the 4aPDD-evoked currents by
73.3615.7% (n=4) and 56.9615.0% (n =4), respectively
(Fig. 6B, C). This finding is a further strong indication of the
involvement of TRPV4 in the current response to 4aPDD. This
pharmacological profile was qualitatively identical in all three
experimental groups. These results overlap those described for the
functional expression of TRPV4 in cultured astrocytes [21], and
they strongly indicate that TRPV4 channels are also functionally
expressed in situ in hippocampal astrocytes of the CA1 region and
moreover, they are up-regulated after H/I.
TRPV4-mediated Activity is Enhanced in Primary Cultured
Astrocytes Isolated from the Ischemic Hippocampal CA1
Region
It is well known that recordings in astrocytes in situ are affected
by their large passive K
+ conductance and by their functional
coupling to other astrocytes. Moreover, from our in situ
experiments we could not rule out that the TRPV4-mediated
currents were evoked primarily in neurons and, as a result, could
then trigger Ca
2+ entry into astrocytes. To address this issue, we
characterized the TRPV4 responses in individual primary
astrocytes isolated from the CA1 region of the hippocampus from
sham-operated rats and those 1H and 7D after H/I and cultured
for 4–5 days. In all experimental groups, immunocytochemical
staining of primary cultured astrocytes with antibodies against
GFAP and GLAST demonstrated two morphologically distinct
types of astrocytes: i.e. astrocytes with a flat polygonal or elongated
soma and astrocytes with a non-flat small oval soma and multiple
long processes (Fig. 7A). The numbers of GFAP-positive flat and
non-flat astrocytes were determined in controls, 1H and 7D after
H/I and expressed as the percentage of the total number of
GFAP-positive cells. Interestingly, the proportions of the two
morphologically distinct types of astrocytes changed in response to
H/I (Fig. 7B). Astrocyte cultures obtained from control rats
comprised 5663.6% of flat astrocytes (number of coverslips,
n=17), while in cultures obtained from ischemic animals their
number significantly declined to 3163.9% in cultures isolated 1H
after H/I (n=17) and to 1764.3% in cultures isolated 7D after
H/I (n=21). In contrast, the percentage of non-flat astrocytes
increased in response to ischemic injury. Nonetheless, their passive
membrane properties were not significantly different from those
observed in flat astrocytes.
The microfluorimetric experiments in vitro revealed an increase
in [Ca
2+]i after the application of 5 mM4 aPDD in astrocytes
isolated from control animals (n=92) as well as those 1H (n=72)
and 7D (n=38) after H/I (Fig. 8A–F). The [Ca
2+]i increase was
significantly higher in astrocytes isolated from animals 7D after H/
I when compared to the other two groups (Fig. 8G left
columns). The Ca
2+ signal was strongly diminished when
4aPDD was applied in aCSFØCa. The different 4aPDD–mediated
Ca
2+ responses of astrocytes isolated from animals 7D after H/I
were also evidenced by the increased number of responding cells
(Fig. 8H top) and by the faster onset of response to 4aPDD
application (Fig. 8H bottom). Furthermore, the steepness of the
onset of response to 4aPDD was also higher in this group. The
differences in these [Ca
2+]i signal parameters observed in
astrocytes were identical in the two morphologically distinct
subpopulations.
In order to identify the current pattern of the two types of
astrocytes in vitro, physiological Na
+- and K
+-containing solutions
were used (Table 1). The cells labeled with LY or Alexa-Fluor
hydrazide during patch clamp recording were identified as
astrocytes using an antibody against GFAP (Fig. 9A, B). The
membrane currents of astrocytes were recorded in response to
hyperpolarizing and depolarizing voltage steps, ranging from
2160 mV to +20 mV at Vh of 270 mV. Isolated astrocytes
cultured for 4–5 days showed two distinct current profiles as
described on freshly isolated astrocytes by Zhou and Kimelberg
Figure 5. 4aPDD-evokes an increase in membrane conductance in astrocytes in situ. (A) Typical current pattern of astrocytes in situ
recorded in the CA1 region of the hippocampus 7 days after H/I at a holding potential of 270 mV (left, the extracellular solution Ext1 contained K
+
and Na
+) and at 240mV (right, K
+ and Na
+ were replaced by Cs
+ in the extracellular solution Ext2). (B) Percentage of hippocampal astrocytes from
sham-operated rats (CTRL), and rats 1H and 7D after H/I that responded to 10 mM4 aPDD (n= number of cells). The threshold for a 4aPDD current
response was 120% of the control ramp current (prior to agonist application), at a voltage of +/2100 mV. The values are presented as mean 6 S.E.M.
Statistical significance was calculated using one-way ANOVA. *p,0.05, significant; **p,0.01, very significant. (C) Time course of 4aPDD-evoked
currents measured from the ramp protocol in astrocytes of controls (blue squares) and astrocytes 1H (green triangles) and 7D after H/I (red circles).
Currents were measured at 2100 mV (white arrowhead) and +100 mV (black arrowhead) in response to a voltage ramp stimulation protocol (see the
inset). (D) Representative traces of steady state currents (same cells as in C) recorded before (in Ext2 solution, dashed line) and during 4aPDD
application (full line) in hippocampal astrocytes of controls (left) and those 1H (middle) and 7D after H/I (right). Representative traces of steady state
currents were obtained at the times indicated by the filled blue squares, green triangles and red circles in C. White and black arrowheads indicate the
applied voltage ramp and the corresponding current traces (see the inset in C).
doi:10.1371/journal.pone.0039959.g005
Table 2. Membrane properties of hippocampal astrocytes
recorded in slices from sham-operated (CTRL) rats and 1H and
7D after H/I.
Vrest (mV) IR (MV)C m (pF) n
CTRL 275.361.2 65.169.7 25.863.7 16
1H H/I 272.361.4 66.866.7 24.963.6 16
7D H/I 269.161.5** 89.469.6 20.462.6 14
The values are presented as mean 6 S.E.M. Asterisks (**p,0.01) indicate very
significant differences between astrocytes from control and ischemic rats.
Abbreviations: resting membrane potential (Vrest), input resistance (IR),
membrane capacitance (Cm), number of cells (n).
doi:10.1371/journal.pone.0039959.t002
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PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e39959Figure 6. Currents evoked by 4aPDD in hippocampal astrocytes in situ are reduced by calcium-free extracellular solution,
Ruthenium Red or RN1734. (A–C, left) Time course of 4aPDD-evoked currents measured from the ramp protocol in astrocytes 7D after H/I (for
the voltage protocol see the inset) prior to and during 4aPDD (10 mM) application and after removing extracellular Ca
2+ (Ext2ØCa, A) or after the
application of TRPV4 inhibitors, such as Ruthenium Red (RR, 10 mM, B) or RN1734 (10 mM, C). (A-C, right) The traces of the steady state currents
(same cells as in left) obtained in Ext2 solution (black lines), during 4aPDD application (red lines) and after removing extracellular Ca
2+ (Ext2ØCa, A)o r
after the application of TRPV4 inhibitors, such as Ruthenium Red (RR, 10 mM, B) or RN1734 (10 mM, C), are indicated by blue lines. Representative
traces of steady state currents were obtained at the times indicated by asterisks of the corresponding colors.
doi:10.1371/journal.pone.0039959.g006
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PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e39959[34]. The flat astrocytes were mainly characterized by passive K
+
currents (Fig. 9C right), whereas non-flat astrocytes showed a
‘‘complex’’ current profile (Fig. 9C left). Since the passive
membrane properties of flat and non-flat astrocytes in each
experimental group were not significantly different, they were
pooled together (Table 3). Also microfluorimetric measurements
did not reveal any differences in 4aPDD-evoked [Ca
2+]i signals
between flat and non-flat astrocytes in each experimental group,
therefore both types of astrocytes were used for the electrophys-
iological analyses.
Similarly to the in situ experiments, TRPV4-specific cationic
current recordings were performed using intra- and extracellular
solutions in which K
+ and Na
+ were replaced with cesium. Under
these experimental conditions, the membrane currents evoked by
hyperpolarizing and depolarizing voltage steps from 2100 mV to
100 mV were strongly diminished (Fig. 9D). The application of
4aPDD (5 mM) produced an increase in membrane conductance
in the astrocytes of controls as well as in those 1H and 7D after H/
I when stimulated with a voltage ramp from 2100 mV to
+100 mV from Vh of 0 mV (Fig. 9E). Exposure to 4aPDD
caused a positive shift of Erev from 25.861.1 mV to
21.160.9 mV (DErev =4.760.9 mV, n=19). The increase in
ramp current upon 4aPDD application was diminished by
74.0611.9% (n=6) by omitting [Ca
2+]e and was depressed by
RR (10 mM) or RN1734 (10 mM) by 79.7610.5% (n=8) and by
69.8618.7% (n=8), respectively (Fig. 10 A–C). Of note, the
4aPDD-evoked outward and inward current amplitudes and
densities were significantly augmented in astrocytes isolated from
the rat hippocampus 7D after H/I (Fig. 11).
Collectively, these results support the tenet that TRPV4
channels are expressed by CA1 primary astrocytes in culture
and that their activity is significantly up-regulated in astrocytes
isolated from the ischemic CA1 region seven days after H/I.
Discussion
In the present study, we provide the first evidence of the
functional expression of TRPV4 channels in CA1 hippocampal
astrocytes in situ. Moreover, this is the first study describing the
impact of global cerebral ischemia in vivo on TRPV4-mediated
currents and intracellular Ca
2+ signaling in hippocampal astro-
cytes. We found that the activity of TRPV4 channels markedly
increases in astrocytes in the CA1 region of the adult rat
hippocampus during the development of astrogliosis induced by
hypoxic/ischemic injury.
It has been shown previously that TRPV4 is widely expressed in
the brain, particularly in the neurons of the pyramidal hippocam-
pal layer as well as in cortical and hippocampal astrocytes
[9,16,21]. However, there are no data demonstrating the
functional expression of TRPV4 channels in astrocytes in situ
under either physiological or pathophysiological conditions, such
as ischemia. In agreement with previous studies [8,16], we showed
the expression of TRPV4 protein in hippocampal pyramidal
neurons as well as in astrocytes of the CA1 region of the
hippocampus in control rats. In addition, we found that TRPV4
immunoreactivity increases in hippocampal astrocytes starting 1
hour after ischemia and reaches maximal levels after 7 days of
reperfusion. Our immunohistochemical analyses revealed that
CA1 pyramidal neurons express TRPV4 in both sham-operated
rats and rats 1 hour after H/I, but not 7 days after H/I. This
decrease in neuronal TRPV4 expression over time is clearly due to
extensive apoptosis in the hippocampal CA1 region wiping out the
majority of CA1 pyramidal neurons [22]. Hippocampal astrocytes
in sham-operated animals showed very low TRPV4 expression,
primarily detected in astrocytic processes enwrapping blood
vessels. It is noteworthy that TRPV4 immunoreactivity markedly
increased 1 hour and 7 days after H/I. Our Western blot analyses
revealed an increase in total TRPV4 protein content 1 hour after
ischemia and, moreover, quantitative RT-PCR analyses detected a
, 2.4-fold increase in TRPV4 mRNA. A similar finding of a rapid
increase in astroglial acetylcholinesterase (AChE) gene expression
(a two- to three-fold increase in readthrough-AChE within 1 h
post-ischemia) has been described previously [35]. These authors
suggested that the stress-induced increase in AChE release is due
to the up-regulation of functional readthrough-AChE isoform
expression, although it is possible that this increased release of
AChE 1 hour post-ischemia may be attributed to increased
readthrough-AChE mRNA transcript stability as well as to an
increase in the rate of AChE transcription. Additionally, the
increase in TRPV4 protein levels observed 1H after H/I might be,
at least partially, due to the enhancement of TRPV4 post-
transcriptional modifications occurring within hours after hypox-
ic/ischemic stress. This could lead to the appearance of additional
bands after 1H and 6H corresponding to different isoforms of
TRPV4, previously detected in astrocytes and shown by Benfenati
and co-authors [21]. Nevertheless, we hypothesize that slower
TRPV4 protein degradation or protein stabilization might also
contribute to the increased amount of TRPV4 protein 1H after
H/I as well.
Curiously, a decline in the total content of TRPV4 protein was
observed starting 1 day after H/I. Since at this time point neurons
are no longer present in the CA1 region of the hippocampus due
to massive neuronal cell death, a decline in the levels of TRPV4
protein in the hippocampal CA1 region is likely to occur, hence
the remaining expression of TRPV4 protein is almost exclusively
in reactive astrocytes. Of note, the enhanced TRPV4 expression
coincided with maximal GFAP expression, astrocyte hypertrophy
and increased astrocytic proliferation [22], which might suggest
that TRPV4-mediated Ca
2+ signaling plays an important role in
the formation of the adaptive response of the gliotic scar.
However, we cannot rule out that increased TRPV4 activity
might be also linked to the initiation of delayed astrocytic cell
death as described by Cao and co-authors [36].
Considering that the physiological role of TRPV4 is mainly
related to its ability to permeate Ca
2+ [37], any investigation of the
functional expression of TRPV4 in astrocytes in situ must include
an analysis of the role of TRPV4 in astroglial [Ca
2+]i signaling. In
control astrocytes, we have recorded low frequency of spontaneous
transient [Ca
2+]i oscillations, while in astrocytes 1 hour and 7 days
after H/I, these oscillations increased 7- and 20-fold, respectively.
Under physiological conditions, similar low frequency of sponta-
neous transient [Ca
2+]i oscillations mediated mainly by the release
of Ca
2+ from internal stores were demonstrated in astrocytes in situ
Figure 7. Immunocytochemical identification of cultured astrocytes dissociated from the CA1 region of the hippocampus. (A) The
distinct morphology of astrocytes isolated from sham-operated rats or from the ischemic hippocampal CA1 region: flat astrocytes (top) and non-flat
astrocytes (bottom) cultured for 4–5 days. Both types of astroglial cells expressed GFAP and GLAST and were also positive for TRPV4. (B) The
incidence of flat and non-flat astrocytes in controls (CTRL) and those isolated from the CA1 hippocampal region 1H and 7D after H/I (n= number of
coverslips). The values are presented as mean 6 S.E.M. Statistical significance was calculated using one-way ANOVA. *p,0.05, significant;
***p,0.001, extremely significant.
doi:10.1371/journal.pone.0039959.g007
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PLoS ONE | www.plosone.org 15 June 2012 | Volume 7 | Issue 6 | e39959[38]. During cerebral hypoxia/ischemia, it is known that astrocyte
damage can be evoked by a rapid increase in [Ca
2+]i [2], a result
in agreement with our data demonstrating augmented spontane-
ous [Ca
2+]i transients in ischemic astrocytes in situ. Our results also
accord well with previous data showing enhanced spontaneous
[Ca
2+]i oscillations in other models of ischemic injury in rodents
(for a review see [39]), in human astrocytes of epileptic patients
[40] and under pathophysiological conditions, such as Rasmus-
sen’s encephalitis [41]. Since the expression of a functional NMDA
receptor subtype 2B was described in astrocytes following ischemia
in vivo and anoxia in vitro [42], we cannot rule out the possibility
that the increased spontaneous Ca
2+ oscillations in post-ischemic
astrocytes in slices might be partially due to arachidonic acid-
mediated potentiation of the current through the NMDA receptor
channels, as previously demonstrated in cerebellar granule cells
[43]. Nevertheless, blocking spontaneous Ca
2+ oscillations with
RN1734 confirmed that these oscillations are also partially
mediated by TRPV4 channels. The duration of reperfusion
following H/I also altered the [Ca
2+]i dynamics. In control
astrocytes and those 1H after H/I, mainly an increased frequency
of [Ca
2+]i transients was observed, while 7 days following ischemia
we also detected sustained Ca
2+ entry after 4aPDD application in
57% of astrocytes, which was completely blocked by Ca
2+-free
extracellular solution (Fig. 3); however, it was insensitive to the
specific TRPV4 inhibitor RN1734 (Fig. 4). In controls and 1H
after H/I, only 3 and 15% of astrocytes showed sustained Ca
2+
entry, respectively. We hypothesize that TRPV4-mediated Ca
2+
entry could initiate an additional Ca
2+ influx via the activation of
other membrane proteins, such as sodium-calcium exchangers
(NCX) [44]. These authors showed that hypoxia also induces
Ca
2+/Na
+ influx via TRPC1, 3, 6 channels, resulting in the
reversal of NCX and thus to an elevation of intracellular Ca
2+ in
PC12 cells. TRPV1-TRPV4 are non-selective cationic channels,
moderately permeable to Ca
2+, with a permeability ratio (PCa/PNa)
between ,6–10 [45]. Such a hypothesis is supported by data
demonstrating that the reverse mode of NCX contributes to
astrocyte and neuronal pathology following experimental trau-
matic brain injury [46]. NCX-mediated fluxes of Ca
2+ in both
forward and reverse modes were found in astrocytes in vitro as well
as those in situ [47,48] and moreover, the activation of astroglial
ionotropic receptors or glutamate transporters induced a marked
elevation of intracellular Na
+, which also switched the exchanger
to the reverse mode [47,49,50]. The reversal of NCX could be also
triggered by mild depolarization [51], which occurs in reactive
astrocytes due to Kir4.1 down-regulation [23].
The question arises: what is the role of TRPV4 in the
augmented [Ca
2+]i signaling found in astrocytes after ischemia.
The possible implication of TRPV4 in enhancing the frequency of
Ca
2+ oscillations in astrocytes after H/I is plausible. In previous
studies, a potential role for TRP channels in a pathophysiological
[Ca
2+]i rise in neurons has been suggested [52–55]. In particular,
TRPM7 and thermal-sensitive TRPV3 have been demonstrated
to mediate a post-ischemic [Ca
2+]i elevation that ultimately leads
to neuronal death [9]. Our data demonstrate that increased
spontaneous [Ca
2+]i oscillations in astrocytes 1 hour and 7 days
after hypoxia/ischemia are paralleled by a 2- to 3-fold increase in
4aPDD-induced Ca
2+ influx. Our finding that spontaneous Ca
2+
oscillations are partially carried by TRPV4 channels in astrocytes
7D after H/I contrasts with a large body of evidence documenting
the involvement of Ca
2+ release from intracellular stores in
astrocytic Ca
2+ oscillations rather than Ca
2+ influx through the
membrane [39]. TRPV4 is a polymodal channel that is activated/
modulated by different intracellular messengers comprising IP3
[56], phosphorylation [57], changes in external and internal Ca
2+
concentrations, PLC activity, and AA metabolites [31], which are
generated via a PLA2 pathway. Of note, in native ciliated
epithelial cells, the IP3-mediated sensitization of TRPV4 positively
modulates its ability to act in response to osmotic stress via
epoxyeicosatrienoic acid, a known PLA2 secondary messenger
[56]. The latter signaling pathway is known to be up-regulated
after ischemia and involved in augmented [Ca
2+]i oscillations.
Intriguingly, in the same study functional coupling to TRPV4 and
intracellular Ca
2+ stores via IP3 signaling was shown to trigger
oscillatory [Ca
2+]i signals in native ciliated epithelial cells [56].
The involvement of TRPV4 in increasing spontaneous [Ca
2+]i
rises in astroglia after an ischemic insult is further corroborated by
the observation that the specific TRPV4 activator 4aPDD
increased the frequency of [Ca
2+]i transients and promoted
sustained Ca
2+ entry 7 days after H/I.
Another explanation for TRPV4 up-regulation could originate
from the proposed role of TRPV4 as mechanosensor or
osmosensor in different cell types, including astrocytes [18,58].
In the present study we showed that not all hippocampal astrocytes
responded to TRPV4-agonist in control rats, but the number of
responding cells significantly increased after ischemia (Fig. 3, 5).
Since our previous studies demonstrated that astrocytes in situ
respond differently to hypo-osmotic stress, a condition simulating
cell swelling frequently observed after ischemia [59], or to oxygen-
glucose deprivation [60], it could be envisaged that under
physiological conditions only the subpopulation of astrocytes that
is more capable of cell volume regulation expresses TRPV4.
Therefore, the up-regulation of TRPV4 after ischemia could be
linked to a required increase in the control of astrocytic volume
under hypoxia/ischemia, a pathological state characterized by
impaired glial volume homeostasis [61]. In addition, astrocytes
release various bioactive substances via Ca
2+- and soluble N-
ethylmaleimide-sensitive factor attachment protein receptor
(SNARE)-dependent exocytosis, which functions as the main
astroglial pathway in glia-neuron signaling [62–64]. Thus, we
suggest that the increased expression/activation of TRPV4
channels in reactive astrocytes might also result in a Ca
2+-
dependent release of cytokines or growth factors. Nevertheless, the
mechanisms of exocytosis in astrocytes after ischemia are still
poorly understood, and further studies using transgenic TRPV4-
Figure 8. Intracellular Ca
2+ measurements in cultured astrocytes dissociated from the hippocampal CA1 region. (A–D) Typical
fluorescence response elicited by 5 mM4 aPDD in cultured hippocampal astrocytes. (A) Two astrocytes in aCSF before 4aPDD application, (B) during
4aPDD application in aCSF, (C) during 4aPDD application in aCSFØCa and (D) during washout with aCSF. (E) Immunocytochemical staining for glial
fibrillary acidic protein (GFAP) to verify astrocyte identity. (F) Representative fluorescence traces of cultured astrocytes isolated from sham-operated
animals (CTRL) and animals 1 hour (1H H/I) and 7 days (7D H/I) after H/I in response to stimulation as in A–D. Note the delay between the 4aPDD
challenge and the onset of the fluorescence increase under the 3 conditions. (G) Histogram of the variation in the fluorescence intensities dF/F0
depicting the maximum intensity upon 4aPDD application in aCSF (4aPDD), the average intensity during the last minute of 4aPDD application in
aCSFØCa (4aPDD in aCSFØCa) and the maximum intensity during washout (aCSF). (H) Histogram of the number of responding cells (top) and histogram
of the 4aPDD response time delay (bottom). Note that in astrocytes 7 days (7D) after H/I, TRPV4-mediated Ca
2+ entry is enhanced and the number of
responding cells is higher when compared to control. The values are presented as mean 6 S.E.M. Statistical significance was calculated using one-way
ANOVA. *p,0.05, significant; **p,0.01, very significant; ***p,0.001, extremely significant.
doi:10.1371/journal.pone.0039959.g008
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sensor in ischemic astrocytes.
Our study clearly shows that the increase in TRPV4-mediated
[Ca
2+]i signaling was positively correlated with the time of
reperfusion following H/I. An alteration in the activation of
TRPV4 channels, possibly via a calmodulin (CaM) binding site or
PLA2 activation pathways as described previously [31,65], could
be involved. Indeed, the activity of these enzymes is known to be
increased during hypoxia [66]. However, the increased TRPV4
current amplitudes and [Ca
2+]i signals were paralleled by
increased immunostaining for TRPV4 in astrocytes in the CA1
region of the hippocampus, thereby suggesting that the elevation
in protein expression could account, at least partially, for the up-
regulation of the TRPV4-mediated [Ca
2+]i signals observed after
ischemia.
Despite the fact that our in situ experiments showed TRPV4-
specific Ca
2+ entry in astrocytes, one can argue that these Ca
2+
transients might be evoked indirectly by the activation of TRPV4
in hippocampal neurons. It is in fact well established that
astrocytes respond to enhanced neuronal activity by a rise in
intracellular Ca
2+ [67]. However, TRPV4-mediated currents/
Ca
2+ entry markedly increased when the neuronal loss was
maximal, e.g. 7 days after ischemia, while 1 hour after ischemia
the changes were less pronounced. However, the selective in vitro
characterization of astroglial TRPV4-responses in adult primary
astrocytes isolated from sham-operated as well as ischemic rats
confirmed that both TRPV4-mediated currents and Ca
2+ entry
were astrocyte-specific and displayed a similar behavior as those in
situ. Notably, the analyses we performed in astrocytes in vitro
confirmed that 4aPDD-evoked Ca
2+ entry was due to the direct
activation of TRPV4 on the astrocytic membrane and showed that
4aPDD-evoked Ca
2+ entry is also markedly increased 7 days after
H/I. Finally, we observed an increase in 4aPDD current in situ,i n
cells that had been counterstained either with Alexa Fluor
hydrazide or LY and that we had clearly identified as astrocytes
by immunohistochemistry.
Our electrophysiological data are in agreement with the
previous pharmacological characterization of TRPV4-mediated
currents in astrocytes in vitro as well as that carried out in
heterologous expression systems with respect to TRPV4 channel
sensitivity to extracellular Ca
2+ decrease and Ruthenium Red
inhibition [21]. Our data are also comparable with the pharma-
cological properties of TRPV4-specific currents described in
hippocampal neurons [16]. Here, we also used a new TRPV4-
specific antagonist, RN1734, which blocks 4aPDD-evoked
currents [32]. Interestingly, the 4aPDD-evoked currents of adult
astrocytes in situ (Fig. 5D) as well as those in vitro (Fig. 9F)
displayed a rather linear current-voltage relationship, similar to
that observed in striatal neurons and HEK293 cells transiently
expressing rat TRPM2 [68]; however, these channels are not
expressed in astrocytes [8]. Even performing point-to-point digital
subtraction of the current traces revealed a rather linear or weakly
rectifying current-voltage relationship of 4aPDD-currents in
astrocytes in situ and in vitro (Fig. S3). A similar current-voltage
relationship was demonstrated in mutated TRPV4 channels [69],
in which both aspartates in the TRPV4 pore region were
neutralized, causing a marked reduction in outward rectification.
Moreover, a modest outward/inward rectification was also shown
in HEK293 cells expressing human TRPV4 [70] and in human
airway epithelial CFT1-LCFSN cells [71]. Since it is not obvious
what underlies the linear TRPV4 current-voltage relationship in
adult astrocytes, we hypothesize that post-translational modifica-
tions, conformational changes of the TRPV4 protein or protein-
protein interactions might contribute to such current behavior.
Generally, we observed marked heterogeneity in TRPV4
channel activity during 4aPDD application even within astrocytes
from sham-operated animals or those after H/I. Heterogeneous
responses of astrocytes to 4aPDD application were described
previously [21]and also recently, by Lanciotti and co-authors [72].
Both groups demonstrated marked differences in the activation/
inactivation of TRPV4–mediated Ca
2+ entry and the response
onset within the recorded population of astrocytes. Such diversity
in TRPV4 channel activity could possibly originate from
alterations in extracellular/intracellular Ca
2+ in the vicinity of
the astrocytic membrane, as these have been shown to strongly
regulate TRPV4 channels [31,45]. In some astrocytes, 4aPDD-
evoked currents displayed either fast activation and fast inactiva-
tion, which have been reported to occur in high extracellular Ca
2+
concentrations [31], or a slow rate of current decay, which might
be attributed to [Ca
2+]i levels. Furthermore, an interaction
between the C- and N-termini of the TRPV4 channel was found
to control the Ca
2+-dependent potentiation of the channel [73],
and the presence of different splice variants, their homomeriza-
tion/heteromerization or post-translational modifications of the
Figure 9. 4aPDD-induced currents in cultured astrocytes dissociated from the hippocampal CA1 region. (A) An image of a Lucifer
Yellow (LY)-loaded astrocyte taken by a digital camera immediately after patch-clamp recording and (B) the same astrocyte identified by
immunostaining with glial fibrillary acidic protein (GFAP). The overlay image shows the co-localization of GFAP with LY. (C) ‘‘Complex’’ and ‘‘passive’’
current patterns in astrocytes in vitro evoked by membrane depolarization and hyperpolarization from the holding potential of 270 mV. The currents
were recorded using K
+- and Na
+-containing intra- and extracellular solutions (Int1 and Ext1). The voltage step protocol is shown in the inset. (D)
Current pattern evoked with a voltage step protocol (see the inset) in cultured astrocytes recorded in intra- and extracellular solutions in which K
+
and Na
+ were replaced by Cs
+ (Int2 and Ext2). Note the marked reduction in membrane conductance. (E) Time course of 4aPDD-evoked currents
measured from the ramp protocol in astrocytes of controls (blue squares) and astrocytes 1H (green triangles) and 7D after H/I (red circles). Currents
were measured at 2100 mV (white arrowhead) and +100 mV (black arrowhead) in response to a voltage ramp stimulation protocol (see the inset). (F)
Representative traces of steady state currents (same cells as in E) recorded prior to (in Ext2 solution, dashed line) and during 4aPDD application (full
line) in cultured astrocytes of controls (left) and those 1H (middle) and 7D after H/I (right). Representative traces of steady state currents were
obtained at the times indicated by the filled blue squares, green triangles and red circles in E. White and black arrowheads indicate the applied
voltage ramp and the corresponding current traces (see the inset in E).
doi:10.1371/journal.pone.0039959.g009
Table 3. Membrane properties of isolated astrocytes from the
CA1 region of the hippocampus from sham-operated (CTRL)
rats and 1H and 7D after H/I.
Vrest (mV) IR (MV)C m (pF) n
CTRL 271.361.9 296.3678.2 18.562.4 9
1H H/I 277.261.4 211.8658.8 26.661.2** 25
7D H/I 271.362.7 265.3655.0 19.762.7 8
The values are presented as mean 6 S.E.M. Asterisks (**p,0.01) indicate very
significant differences between astrocytes from control and ischemic rats.
Abbreviations: resting membrane potential (Vrest), input resistance (IR),
membrane capacitance (Cm), number of cells (n).
doi:10.1371/journal.pone.0039959.t003
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channel activation/desensitization following H/I. Until now, there
are no published data describing TRPV4 splice variants in rats;
however, the existence of 5 different splice variants was described
for the human TRPV4 channel [74]. Moreover, 4aPDD might act
on the lipid environment more efficiently in vitro than in situ and
thus differentially modulate TRPV4 channels. The physiological
relevance of such a lipid-modulated mechanism of activation has
been suggested for other mechano-gated channels [75]. Finally,
astrocyte heterogeneity within the hippocampal CA1 region might
be the reason for the observed variations in TRPV4 responses. A
number of publications have appeared recently showing marked
astrocyte heterogeneity even within an individual CNS region,
with different astrocyte coupling or the expression of ion channels,
Figure 10. Currents evoked by 4aPDD in astrocytes in vitro are reduced by calcium-free extracellular solution, Ruthenium Red or
RN1734. (A–C, left) Time course of 4aPDD-evoked currents measured from the ramp protocol in astrocytes isolated from the hippocampus 7D after
H/I (for the voltage protocol see the inset) prior to and during 4aPDD (5 mM) application and after removing extracellular Ca
2+ (Ext2ØCa, A) or after the
application of TRPV4 inhibitors, such as Ruthenium Red (RR, 10 mM, B) or RN1734 (10 mM, C). (A–C, right) The traces of steady state currents (same
cells as in left) obtained in Ext2 solution (black lines), during 4aPDD application (red lines) and after removing extracellular Ca
2+ (Ext2ØCa, A) or after
the application of TRPV4 inhibitors, such as Ruthenium Red (RR, 10 mM, B) or RN1734 (10 mM, C), are indicated by blue lines. Representative traces of
steady state currents were obtained at the times indicated by asterisks of the corresponding colors.
doi:10.1371/journal.pone.0039959.g010
Figure 11. Changes in TRPV4-mediated currents in response to hypoxia/ischemia. Histograms of 4aPDD-evoked changes in current
amplitudes (A top) and current densities (A bottom) at +100 mV and current amplitudes (B top) and current densities (B bottom) at 2100 mV in
control astrocytes (CTRL), and those isolated from rats 1H and 7D after H/I. The values are presented as mean 6 S.E.M. Statistical significance was
calculated using one-way ANOVA. *p,0.05, significant; **p,0.01, very significant.
doi:10.1371/journal.pone.0039959.g011
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reactive astrocytes in post-ischemic tissue might originate not only
from proliferating astrocytes [22], but also from polydendrocytes
[77], which might further contribute to the heterogeneity within
the reactive astrocyte population.
In agreement with our Ca
2+ imaging data, electrophysiological
analysis also confirmed that after H/I astrocytes display increased
TRPV4 currents. These changes in TRPV4 current amplitude
were not significant in situ (Fig. S2). However, this result is not
surprising because the expression of passive conductance in
astrocytes in situ makes the isolation of different currents in these
cells quite difficult [23]. Importantly, we found that TRPV4-
mediated currents in astrocytes in vitro are significantly increased 7
days after H/I; however, 4aPDD-evoked Ca
2+entry/currents were
not enhanced in astrocytes isolated from the hippocampal CA1
region 1H after H/I. We hypothesize that astrocytes isolated
during the acute stages of reperfusion could recover after their
transfer into culture medium and therefore their responses to
4aPDD were similar to those recorded in controls. In contrast, 7D
after H/I the changes in reactive astrocytes are rather permanent
and therefore not reversible by their culturing.
In addition, we found that the incidence of astrocytes
responding to 4aPDD increases with the time of reperfusion and
that the TRPV4-immunoreactivity of an individual reactive
astrocyte in the CA1 region significantly increases, correlating
well with the increasing number of TRPV4-positive astrocytes in
the hippocampal CA1 region during reperfusion (Fig. 1, 3H, 5B,
8H). Although we were not able to detect a significant increase in
TRPV4-current amplitude in situ following ischemia, intracellular
Ca
2+ imaging revealed that Ca
2+ entry mediated by TRPV4
channels is significantly augmented in astrocytes 1 H and 7D after
H/I. A significantly larger number of cells was analyzed by
intracellular calcium imaging compared to patch-clamp recording
in situ, which might result in the discrepancies between TRPV4-
mediated Ca
2+ entry and current amplitude. In contrast to
intracellular Ca
2+ measurements, where relatively intact cells are
recorded, the patch-clamp technique in the whole-cell configura-
tion significantly affects the astrocytic intracellular environment,
possibly diluting the regulatory molecules required for enhanced
TRPV4 activity.
Collectively, the data obtained in vitro validate the in situ
analyses, thus identifying TRPV4 as one of the channels involved
in the pathophysiological [Ca
2+]i signals in ischemic astroglia.
Nevertheless, it still remains uncertain how astrocytic TRPV4
channels are activated under physiological or pathophysiological
conditions. Generally, astrocytes play a significant role in ionic/
neurotransmitter and water homeostasis and therefore, neuronal
activity leading to enhanced K
+/glutamate uptake in astrocytes
and resulting in the swelling of astrocytic processes enwrapping the
synapses might be an initial trigger for TRPV4 activation, as these
channels act as mechanosensors. Also, subtle changes in extracel-
lular ionic concentrations in the vicinity of the astrocytic
membrane might result in TRPV4 activation under physiological
conditions, as these channels act as osmosensors. Recent data
indicate that astrocytes contain a TRPV4/AQP4 complex [18]
that constitutes a key element in CNS volume homeostasis by
acting as an osmosensor that couples osmotic stress to downstream
signaling cascades. Additionally, the fact that several ion channels,
such as Kir channels (specifically Kir4.1), AQP4 and TRPV4, are
co-expressed in the astrocytic endfeet [78–80] points to the
importance of membrane protein interactions of membrane
microdomains that are devoted to extracellular K
+ buffering/
glutamate uptake and water homeostasis. Thus, astrocytic swelling
via PLA2 activation, the release of AA from membrane
phospholipids followed by cytochrome P450 epoxygenase-depen-
dent AA metabolism producing 59,69 epoxyeicosatrienoic acid
might act as a TRPV4 channel activator. Under pathophysiolog-
ical conditions, tissue damage and inflammation result in the
release of pro-inflammatory mediators, which may in turn activate
intracellular signaling pathways and downstream kinases, such as
PKC and PKA, and consequently enhance the activation the
TRPV4 ion channel by phosphorylation [57].
Taken together, we show that TRPV4 channels are involved in
the increase of [Ca
2+]i signaling occurring after cerebral hypoxia/
ischemia in the hippocampal astrocytes of adult rats. The TRPV4-
mediated [Ca
2+]i elevation is at least partially due to the increased
expression of TRPV4 protein and is further increased with time
following the ischemic insult. Because alterations in [Ca
2+]i
dynamics in astroglia are associated with the modulation of
physiological and pathophysiological processes (for a review see
[81,82]), our study identifies a novel molecular target to be
explored in order to unravel astrocyte signaling after ischemia
reperfusion and to define more clearly the astrocyte-mediated
pathogenetic processes in acute brain disorders.
Supporting Information
Figure S1 Quantification of TRPV4 protein levels in the
hippocampal CA1 region following hypoxia/ischemia.
(A) Western blots demonstrating the changes in TRPV4 and
GFAP protein levels in response to hypoxic/ischemic (H/I) injury.
b-actin was used as a control for sample loading. Squares A1-6
(red) and A1’-69 (blue) indicate the zones where TRPV4
quantification was carried out, containing 1 or 2 TRPV4 bands,
respectively. Squares B1-6 (green) and C1-6 (yellow) indicate the
zones where GFAP and b-actin quantification was carried out,
respectively. The effect of H/I on TRPV4 levels during the time of
reperfusion was evaluated in each individual Western blot and
expressed as the percent increase/decrease related to the TRPV4
content in control samples (CTRL), which was set as 100%. To
obtain the area corresponding to the TRPV4 protein level at each
time-point, the area A1/A1’ (TRPV4) was divided by the area C1
(b-actin) and this value was set as 100%. (B) Single Western blot
quantification that demonstrates an increase in TRPV4 protein
levels 1H after H/I regardless of the selected zones (A1-6 or A1’-
69) and an increase in GFAP content 3 and 7 days (3D, 7D) after
H/I.
(TIF)
Figure S2 Changes in TRPV4-mediated currents in
astrocytes in situ following hypoxia/ischemia. Histo-
grams of 4aPDD-evoked changes in current amplitudes at
+100 mV (left) and -100 mV (right) in control astrocytes
(CTRL) and astrocytes in slices prepared from rats 1H and 7D
after H/I.
(TIF)
Figure S3 Isolation of 4aPDD currents –point-to-point
current subtraction. The 4aPDD- current traces obtained
after point-to-point subtraction of ramp current traces recorded
prior to 4aPDD application (a) and those recorded during 4aPDD
application (b) in astrocytes in situ (A) and astrocytes isolated from
the adult rat hippocampal CA1 region (B) of sham-operated rats
(CRTL) and rats 1 hour and 7 days after hypoxia/ischemia (1H,
7D H/I; see the voltage ramp protocol in the inset). Note the
linear I-V relationship of the 4aPDD-sensitive current (b-a)
detected in astrocytes in situ as well as in vitro in sham-operated
rats (blue trace), while a modest outward rectification of the
4aPDD current was observed in post-ischemic astrocytes (red and
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PLoS ONE | www.plosone.org 21 June 2012 | Volume 7 | Issue 6 | e39959green traces). Typical 4aPDD-current traces obtained after point-
to-point subtraction of ramp current traces recorded in astrocytes
in situ (C) and astrocytes in vitro (D) prior to (a) and during 4aPDD
application (b) and in response to the removal of extracellular Ca
2+
(Ext2ØCa, top) or after the application of TRPV4 inhibitors, such
as 10 mM RN1734 (middle) or 10 mM,ruthenium red (RR,
bottom, c). Red traces represent the 4aPDD-sensitive current (b-
a) and blue traces represent the remaining current after applying
the inhibitors (c-a). Black and white arrowheads indicate the
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